Authors:
SIEGEL DS
ZHANG X
FEINMAN R
TEITZ T
ZELENETZ A
RICHON VM
RIFKIND RA
MARKS PA
MICHAELI J
Citation: Ds. Siegel et al., HEXAMETHYLENE BISACETAMIDE INDUCES PROGRAMMED CELL-DEATH (APOPTOSIS) AND DOWN-REGULATES BCL-2 EXPRESSION IN HUMAN MYELOMA CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(1), 1998, pp. 162-166
Citation: Ds. Siegel et al., THE ADOPTION OF ADVANCED MANUFACTURING TECHNOLOGIES - HUMAN-RESOURCE MANAGEMENT IMPLICATIONS, IEEE transactions on engineering management, 44(3), 1997, pp. 288-298
Authors:
SIEGEL DS
JAGANNATH S
DESIKAN KR
TRICOT G
BRACY D
MADDOX S
BARLOGIE B
VESOLE DH
Citation: Ds. Siegel et al., FEASIBILITY OF HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELLSUPPORT FOR MULTIPLE-MYELOMA PATIENTS OVER THE AGE OF 70, Blood, 88(10), 1996, pp. 508-508
Authors:
GOY A
PASSALARIS T
XIAO YH
MILLER WH
SIEGEL DS
ZELENETZ AD
Citation: A. Goy et al., THE PML GENE IS LINKED TO A MEGABASE-SCALE INSERTION DELETION RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM/, Genomics, 26(2), 1995, pp. 327-333
Authors:
NIESVIZKY R
SIEGEL DS
BUSQUETS X
NICHOLS G
MUINDI J
WARRELL RP
MICHAELI J
Citation: R. Niesvizky et al., HYPERCALCEMIA AND INCREASED SERUM INTERLEUKIN-6 LEVELS INDUCED BY ALL-TRANS-RETINOIC ACID IN PATIENTS WITH MULTIPLE-MYELOMA, British Journal of Haematology, 89(1), 1995, pp. 217-218